Research Topics
Species | Fernando FigueroaSummaryAffiliation: Universidad de los Andes Location: Santiago, Chile Summary: Pontificia Universidad Católica de Chile Medical School. Santiago Medical Doctor. Universidad de Chile. Summa cum laude. Santiago PROFESSOR OF MEDICINE, School of Medicine, Universidad de los Andes. Santiago PROGRAM DIRECTOR, TRANSLATIONAL RESEARCH IN CELL THERAPY. School of Medicine, Universidad de los Andes MEDICAL DIRECTOR, UNIT OF RHEUMATOLOGY. School of Medicine, Universidad de los Andes Publications
| Collaborators
|
Detail Information
Publications
Mesenchymal stem cell injection ameliorates chronic renal failure in a rat modelSandra Villanueva
Laboratory of Integrative and Molecular Physiology, Los Andes University, Santiago, Chile
Clin Sci (Lond) 121:489-99. 2011..It is precisely to this point that the present study aims to contribute...
Opposing effect of mesenchymal stem cells on Th1 and Th17 cell polarization according to the state of CD4+ T cell activationFlavio Carrion
Laboratorio de Inmunologia, Facultad de Medicina, Universidad de Los Andes, Avenida San Carlos de Apoquindo 2200, Santiago de Chile, Postal code 7620001, Santiago, Chile
Immunol Lett 135:10-6. 2011..These results suggest that the therapeutic use of MSCs in vivo might exert opposing effects on disease activity, according to the time of therapeutic application and the level of effector T cell activation...
[Cardiovascular assessment of non diabetic patients on hemodialysis]Sonia Kunstmann
Facultad de Medicina, Universidad de Los Andes, Santiago, Chile
Rev Med Chil 137:351-60. 2009..Diabetes mellitus is an important risk factor for cardiovascular complications among patients on hemodialysis. However, the incidence of these complications among non diabetic patients on hemodialysis is not well known...
Patient self-administered joint tenderness counts in rheumatoid arthritis are reliable and responsive to changes in disease activityFernando Figueroa
Department of Medicine, Universidad de Los Andes, Santiago de Chile, Chile
J Rheumatol 34:54-6. 2007..To examine whether self-assessment of tender and swollen joints by patients with rheumatoid arthritis (RA) can be used to evaluate changes in disease activity instead of joint counts by physicians...
[Study of polymorphism of Fc gamma IIa receptors in Chilean patients with systemic lupus erythematosus]Flavio Carrion
Facultad de Medicina, Universidad de Los Andes, Facultad de Medicina, Pontificia Universidad Catolica de Chile, Facultad de Medicina, Sede Oriente, Universidad de Chile
Rev Med Chil 131:11-8. 2003..The H131 allele binds IgG2 efficiently, whereas R131 binds it poorly. Because IgG2 is a poor activator of the classical complement pathway, the H131 is essential for the disposal of IgG2 immune complexes...
[Presence of bacterial DNA in valvular tissue of patients with chronic rheumatic heart disease]Fernando E Figueroa
Laboratorio de Inmunologia, Facultad de Medicina, Universidad de Los Andes, Santiago, Chile
Rev Med Chil 135:959-66. 2007..However, recent studies concerning the antigenic specificity and clonality of intralesional lymphocytes have revealed oligoclonal expansions characteristic of an antigen specific response, that might be related to GAS...
Restriction in the usage of variable beta regions in T-cells infiltrating valvular tissue from rheumatic heart disease patientsF Figueroa
Laboratory of Immunology, Faculty of Medicine, Universidad de Los Andes, Santiago, Chile
J Autoimmun 19:233-40. 2002....
Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?Flavio A Carrión
Laboratorio de Inmunología Celular y Molecular, Facultad de Medicina, Universidad de Los Andes, Avda San Carlos de Apoquindo 2200, Las Condes, Santiago 7620001, Chile
Stem Cell Res Ther 2:23. 2011..In addition, they suggest that there is much to be learned from the basic and clinical science of MSCs in order to reap the full potential of these multifaceted progenitor cells in the treatment of autoimmune diseases...
[Effects of bromocriptine in patients with active rheumatoid arthritis]F Figueroa
Facultad de Medicina Universidad de Los Andes, Las Condes, Santiago de Chile
Rev Med Chil 126:33-41. 1998..Prolactin (PRL) can induce T-cell proliferation and macrophage activation. Elevated PRL levels have been described in patients with rheumatoid arthritis (RA)...
